The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-8-hydroxy-5-(1-hydroxy-2-(3-methoxy-4-(3-phenylpropoxy)phenethylamino)ethyl)quinolin-2(1H)-one ID: ALA3800400
PubChem CID: 102262219
Max Phase: Preclinical
Molecular Formula: C29H32N2O5
Molecular Weight: 488.58
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
Standard InChI: InChI=1S/C29H32N2O5/c1-35-27-18-21(9-13-26(27)36-17-5-8-20-6-3-2-4-7-20)15-16-30-19-25(33)22-10-12-24(32)29-23(22)11-14-28(34)31-29/h2-4,6-7,9-14,18,25,30,32-33H,5,8,15-17,19H2,1H3,(H,31,34)/t25-/m0/s1
Standard InChI Key: PNROEQYQIZJINW-VWLOTQADSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 2.6973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6486 1.3517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2985 -2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3387 -3.5964 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0002 -3.7511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0022 -5.2520 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2960 -6.0049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2940 -7.5058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5923 -8.2588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5924 -9.7588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8915 -10.5087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1905 -9.7587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1904 -8.2587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8914 -7.5087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4886 -7.5055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.4869 -6.3055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4888 -10.5117 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.4867 -12.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7850 -12.7655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7829 -14.2663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0812 -15.0194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0813 -16.5194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3803 -17.2694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6794 -16.5193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6793 -15.0193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3803 -14.2693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 6 1 0
5 3 1 0
3 4 2 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
1 12 2 0
10 13 1 0
13 14 1 1
13 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
23 25 1 0
25 26 1 0
22 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
36 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 488.58Molecular Weight (Monoisotopic): 488.2311AlogP: 4.12#Rotatable Bonds: 12Polar Surface Area: 103.81Molecular Species: BASEHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.51CX Basic pKa: 9.65CX LogP: 3.42CX LogD: 2.48Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.22Np Likeness Score: 0.08
References 1. Weichert D, Stanek M, Hübner H, Gmeiner P.. (2016) Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists., 24 (12): [PMID:27132867 ] [10.1016/j.bmc.2016.04.028 ]